Evidence map›Paper›PMID 36288047›Full record

ReviewTropical medicine and infectious disease2022

Updating the Insecticide Resistance Status of

Ramdan Zulfa, Wei-Cheng Lo, Po-Ching Cheng, Martini Martini, Ting-Wu Chuang

Abstract readReview
In one paragraph

Review in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. EngineeredInsects · 2026
    Article
  3. Article
  4. Acceptability of Integrated Vector Management ofTropical medicine and infectious disease · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. TheFrontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ramdan ZulfaInternational Master Program in Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-6475-4192
Wei-Cheng LoMaster Program in Applied Epidemiology, College of Public Health, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-4818-8263
Po-Ching ChengDepartment of Molecular Parasitology and Tropical Diseases, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0002-1172-2485
Martini MartiniDepartment of Epidemiology and Tropical Diseases, College of Public Health, Diponegoro University, Semarang City 50275, Indonesia.ORCID 0000-0002-6773-1727
Ting-Wu ChuangDepartment of Molecular Parasitology and Tropical Diseases, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.ORCID 0000-0001-8359-8172

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThis meta-analysis and systematic review explored the spatial and temporal patterns of insecticide resistance in Asia from 2000 to 2021. PubMed, Scopus, EbscoHost, and Embase were used to enhance the search capability. The random-effects model was applied for the 94 studies that met our inclusion criteria for qualitative synthesis and meta-analysis.

resultsFour major insecticides were studied (malathion, dichlorodiphenyltrichloroethane, permethrin, and deltamethrin). Dichlorodiphenyltrichloroethane resistance rates were high in both

conclusionsInsecticide resistance in both

Indexed as

Aedes aegyptiAedes albopictusAsiainsecticide resistancemeta-analysis

Identifiers

PMID36288047
PMCPMC9607256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.